Biofil Chemicals & Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026, to consider and approve the Un-Audited Financial Results of the Company for the first Quarter ended on 30th June, 2026 along with Limited Review Report thereon; and to consider other routine matters with the permission of the chair.
The above information is a part of company’s filings submitted to BSE.